Skip to main content

Seaport Therapeutics, Inc 8-K, filed Nov 2, 2026

Seaport Therapeutics, Inc. (SPTX)

8-K 2026-11-02 For: 2026-11-02
View Original
Added on November 02, 2026

About this 8-K

Seaport Therapeutics, Inc filed this 8-K on November 2, 2026.

Seaport Therapeutics reported a third-quarter 2026 net loss of $26.4 million, versus $22.5 million a year earlier. Cash, cash equivalents and investments totaled $403.8 million at September 30, 2026, expected to fund operations into 2029. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits